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Upon  agonis t  b ind ing  the  h e t e r o m e r i c  g lucocor t i co id  r e c e p t o r  complex  unde rgoes  a c o n f o r m a t i o n a l  
change  ( r e c e p t o r  ac t ivat ion) .  This  event  involves the dissocia t ion o f  a d i m e r  of  90 kDa hea t  shock 
pro te ins .  Whereas  r e c e p t o r  ac t iva t ion  in cytosol ic  assays is bo th  r ap id  and  i r revers ib le ,  less is known 
abou t  the  r e c e p t o r  ac t iva t ion  and  t r ans loca t i on  in in tac t  cells du r ing  chal lenge wi th  an agonist .  In 
this p a p e r  we r e p o r t  on the  r e c e p t o r  s ta tus  of  g lucocor t i co id-sens i t ive  m u r i n e  $49 l y m p h o m a  cells 
du r ing  d e x a m e t h a s o n e  exposure .  By th ree  d i f fe ren t  assays, l igand ( re)b inding,  nuc l ea r  t r ans loca t i on  
and  hsp90 c o - i m m u n o p r e c i p i t a t i o n ,  it was found  tha t  the m a j o r i t y  of  the  g lucocor t i co id  r e c e p t o r  
p r o t e i n  was in a n o n - a c t i v a t e d  c o n f o r m a t i o n .  F u r t h e r m o r e ,  p ro longed  exposure  to d e x a m e t h a s o n e  
did not  resu l t  in inc reased  levels of  ac t iva ted  recep to rs .  By assessing r e c e p t o r  ac t iva t ion  in situ 
we found  tha t  physiological  t e m p e r a t u r e  was less effective in dissociat ing hsp90 c o m p a r e d  to 
r o o m  t e m p e r a t u r e .  These  f indings ind ica te  tha t  the physiological  t e m p e r a t u r e  nega t ive ly  cont ro l s  
r e c e p t o r  ac t iva t ion ,  p r o b a b l y  due to a t h e r m o l a b i l e  i n t e r ac t i on  be tween  the  h o r m o n e  and  its cognate  
r ecep to r .  
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INTRODUCTION 
Glucocorticoid hormones (GC) modulate gene tran- 
scription in a tissue-specific manner [1]. In tissues 
of lymphatic origin they are capable of mediating the 
induction of apoptosis and GC-hormones are therefore 
included in most protocols for treatment of leukemia 
and lymphoma [2, 3]. The  intracellular signal transduc- 
tion of the hormone is mediated by the glucocorticoid 
receptor (GR), a protein capable of interacting with the 
ligand as well as with the steroid responsive elements 
in the DNA [4]. 
Several lines of evidence have indicated that un- 
liganded GRs are complexed to a dimer of 90 kDa heat 
shock proteins (hsp90) [5-8]. Loss of these heat shock 
proteins results in a decrease in affinity of the receptor 
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for glucocorticoid by at least 100-fold [9, 10]. These 
observations have led to the suggestion that hsp90 
maintains the receptor in a conformation capable 
of binding the hormone with high affinity. Both the 
steroid binding pocket as well as the region of inter- 
action with hsp90 are located at the carboxyl terminal 
part of the protein. Truncated receptors devoid of this 
region are constitutively active [11, 12], underscoring 
another major function of hsp90 in the receptor com- 
plex: suppression of DNA binding activity. Ligand 
binding facilitates the dissociation of hsp90 from the 
complex, a process referred to as receptor activation 
[10]. Activated GRs are DNA-binding proteins 
and can be isolated from the nuclear compartment. 
This process of intracellular redistribution is called 
translocation. 
Much of the assembled data on the interaction 
between hsp90 and the receptor stem from laboratory 
studies in which ligand binding and receptor activation 
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were assayed in cytosolic preparations at temperatures 
ranging from 15-25°C. In these studies receptor acti- 
vation has been found to be rapid, quantitative and 
irreversible [13-17]. In intact, glucocorticoid respon- 
sive $49 cells assayed at physiological temperature, 
steroid-induced nuclear translocation of the GR ranged 
from 40% as measured by Distelhorst and Howard [18] 
to almost 100% according to Segnitz and Gehring [19]. 
As it is generally assumed that nuclear translocation 
and receptor activation are concurrent phenomena this 
would logically lead to a significant loss of ligand 
binding capacity. These results are, however, in con- 
trast with our previous observation that no loss of 
specific steroid binding was observed in such cells 
previously exposed to dexamethasone [20]. These find- 
ings would suggest that in intact, GC-responsive cells 
substantial amounts of receptor were not activated and 
thus still complexed to hsp90. 
We have therefore studied the apparent discrepan- 
cies between cytosolic and whole-cell assays by investi- 
gating the receptor status in $49 cells after various 
lengths of dexamethasone incubation in three different 
ways, specific ligand (re)binding, hsp90 association 
and receptor translocation. Furthermore, we have 
examined the effect of temperature on in situ activation 
of liganded receptors. In doing so we obtained evidence 
that the majority of glucocorticoid receptors in steroid- 
challenged $49 cells are in a non-activated confor- 
mation, even under conditions leading to maximal lysis. 
Finally, by assessing the receptor activation in concen- 
trated cytosols we found that a low temperature (20°C), 
often used to activate cytosolic receptors, is more 
effective in dissociating hsp90 from the complex than 
the physiological temperature of 37°C. 
M A T E R I A L S  A N D  M E T H O D S  
Cell lines and cytosol preparation 
Dexamethasone-sensitive $49 mouse lymphoma 
cells with a doubling time of approximately 12 h were 
maintained as described previously [20]. Cytosols were 
prepared from exponentially growing cell cultures. 
Prior to harvesting the cells were routinely checked 
for viability by light microscopy. Approximately 
10 9 cells were collected by gentle centrifugation (800g) 
and washed twice with cold phosphate buffered 
saline. After the last wash the cells were spun down at 
1200g and the volume of cell pellet (400-600 #1) was 
measured. The cells were lysed by diluting the cell 
pellet with an equal volume of ice-cold lysis buffer. 
Next, the slurry was transferred to a Dounce homogen- 
izer and the cells were disrupted by 20 strokes. 
The mixture was subsequently centrifuged for 1 h at 
100,000g in the cold. The resulting supernatant (cyto- 
sol) was aliquoted and either stored at - 7 0 ° C  or 
directly used in the experiments. Protein concentration 
of the cytosols were determined using a protein assay 
kit (Bio-Rad, Richmond, U.S.A.). 
Chemicals and antibodies 
All cell culture reagents were from Gibco (Paisley, 
Scotland). Immobilon-P PVDF blotting membrane 
was from Millipore (Bedford, U.S.A.). Chemicals were 
of analytical grade and obtained from Boehringer 
Mannheim (Mannheim, Germany), except for TES (2 
[tris (hydroxylmethyl)methyl- amino]- 1 - ethanesulfonic 
acid) which was from Janssen Chimica (Geel, Belgium) 
and acrylamide from Serva (Heidelberg, Germany). 
Protein A Sepharose was from Pharmacia LKB 
(Uppsala, Sweden). Anti-GR antibody MAI-510 
(clone BuGR2) and the anti-hsp90 antibody MA3-010 
(which reacts similar to the AC88 monoclonal) were 
from Affinity BioReagents Inc. (Neshanic Station, 
U.S.A.). Anti-receptor antibody GR49 was a generous 
gift from Dr H. M. Westphal (Marburg, Germany). 
Goat-anti-mouse peroxidase conjugated IgG was from 
Pierce (Rockford, U.S.A.) and 125I-labeled sheep- 
anti-mouse (16/~Ci/#g) and [1,2,43H]dexamethasone 
(37 Ci/mmol) were purchased from Amersham Inter- 
national (Bucks., England). 
Buffers 
P B S  ÷ ÷: phosphate buffered saline with 2.2raM 
CaC12 and 1.2 mM MgC12; TBS: Tris buffered saline; 
20mM Tris pH 7.4, 150mM NaC1, TEG: 10raM 
TES,  pH7.4,  4 m M  EDTA, 10% (v/v) glycerol; 
blocking buffer:  0.5 mM EDTA, 0.5% (v/v) Tween- 
20, 0.15% (w/v) bovine serum albumin in TBS; lysis 
buffer:  10 mM Hepes, pH 7.4, 1 mM EDTA, 1 mM 
D T T ,  proteases inhibitors: PMSF, anti-trypsin; f r ac -  
t iona t ion  buffer:  phosphate buffer 20mM, pH 7.4, 
250 mM sucrose, 1 mM EDTA. 
[3H]dexamethasone binding experiments 
The number of specific dexamethasone binding sites 
was determined using a modified version of the whole- 
cell binding assay as used by Costlow et al. [21] and 
was described previously [20]. Dissociation of the 
ligand from the GR in intact $49 cells was accom- 
plished by collecting the [3H]dexamethasone labeled 
cells by centrifugation (800g) and resuspension in 
agonist-free growth medium at 37°C at a density of 
approx. 107 cells/ml. Rebinding with the radio-labeled 
steroid was done by returning the cells to the same 
medium as used for the initial binding experiment. 
Immunoprecipitation and Western blotting 
Cytosol (100#1) was incubated with 2.5#g of 
MA1-510 receptor antibody for 2 h in the cold. Sub- 
sequently the cytosol was diluted with 100/~1 T E G M  
(TEG buffer with 20 mM Na2MoO4) and 30/~1 Protein 
A Sepharose [20% (w/v)] and gently mixed for another 
2 h. The sample was concentrated by centrifugation 
(14,000g) for 10min and washed five times with 
1 ml of cold T E G M  buffer. The immunopellets were 
resuspended in 2 × sample buffer and boiled for 
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5 min. Subsequently the Protein-A-Sepharose beads 
were spun down and the supernatant was applied 
to SDS-PAGE (7.5 or 12%). After separation the 
proteins were transferred to PVDM membranes (2 h at 
400 mA). The membranes were incubated in blocking 
buffer for 1 h at room temperature and subsequently 
incubated with the appropriate antibody dilutions 
(1:300 for the MA3-010 monoclonal and 1:500 for 
the BuGR2 clone). Primary antibody incubations were 
always performed overnight in the cold. Unbound 
antibody was removed by washing the membrane twice 
with cold TBS. As a second antibody, goat-anti- 
mouse horseradish conjugated IgG (1:3000 in block- 
ing buffer) was used; 2-3 h at room temperature. 
The proteins were visualized by reacting the mem- 
branes with 5 ml 4-chloro-l-naphthol (3 mg/ml) and 
100#M HEOe in 25ml of TBS. For quantification 
the immunoblots were incubated with [125I]RAM 
(sheep-anti-mouse) IgG (2 #Ci in 10ml of blocking 
buffer). Unbound label was removed by washing 
the membranes three times with cold TBS buffer. 
Membranes were left to dry before an autoradiogram 
was made or the stained bands were excised for 
quantification by scintillation counting. 
Nuclear translocation of GRs 
$49 cells are collected, washed twice, resuspended in 
fractionation buffer and disrupted by freeze/thawing 
in liquid nitrogen (~50 x 106cells/ml). The nuclear 
pellet was separated from the cytoplasm by centrifu- 
gation at 14,000g in the cold for 1 h. The resulting 
pellet was washed twice with cold 250 mM NaC1 and 
subsequently incubated with 500 mM NaC1 for 30 min 
at room temperature to extract activated receptors. 
The extracted proteins were precipitated with cold 
TCA (10% v/v) and washed twice with cold TCA (1% 
v/v). The pellets were boiled in sample buffer and the 
pH was adjusted with 5 M NaOH. Cell equivalent 
amounts of protein were separated on SDS-PAGE and 
after transfer and blotting (MoAb GR49; 1:10,000) 
analyzed for receptor protein. 
RESULTS 
Pulse-chase dexamethasone incubations in $49  cells 
Glucocorticoid-sensitive $49 cells are rapidly lysed 
by incubation in 10 -7 M of dexamethasone [20]. To 
assess the minimum time required for induction of a 
lytic response the cells were incubated with the steroid 
for various time intervals and subsequently resus- 
pended in agonist-free growth medium. Apoptotic 
cells were scored microscopically after 24 h (Fig. 1). 
A minimal incubation time of 8-10 h was found to be 
required for committing the cells for lysis, during 
which the cells became arrested in the G1 phase of the 
cell cycle as described previously [22]. 
Dexamethasone challenged $49  cells can be relabeled with 
[ 3 H ]dexame thasone 
The reversibility of dexamethasone-induced lysis 
suggested that the receptor-mediated signalling was 
reversible during agonist incubations up to 8 h. High 
affinity ligand binding capacity, indicative for non- 
activated receptors, was therefore assayed by measur- 
ing the dexamethasone (re)binding capacity. $49 cells 
were labeled at 37°C for 1 h with the tritiated ligand 
and stable receptor-ligand association was determined 
after a post-incubation dilution step (PID) at room 
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Fig. I.  D e x a m e t h a s o n e - i n d u c e d  cell  death  in S49 cells .  S49 cel ls  were  incubated  with I 0 -7  M of  d e x a m e t h a s o n e  
and at the indicated  t i m e s  co l l ec ted  and r e s u s p e n d e d  in agonis t - free  m e d i u m .  The percentage  of  lysed  cel ls  
was  scored  after 24 h. P r e s e n t e d  data  are the average  o f  tr ipl icate  exp er imen t s .  
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Fig. 2. Dissociat ion and rebinding  of  [3H]dexamethasone  in 849 cells. $49 cells  were  incubated with 
2 / iC i /ml  ( 0 . 5 x l 0 - S M )  [3H]dexamethasone for  l h  at 37°C (t o value). Subsequent ly  the cells were 
t r a n s f e r r e d  to agonis t - f ree  m e d i u m  for  l h  and then  r e t u rn ed  to the labeling m e d i u m .  At indicated  
t imes  specific dexame thasone  binding was de termined .  Data  points  are  the m e a n  SEM of  three 
independent  exper iments .  
temperature.  I f  the P ID  was performed at 37°C a 
progressive loss (tl/2 = 18min) of cell-bound dexa- 
methasone was observed (Fig. 2), compared to stable 
binding of  the ligand at 20°C [18]. After dissociation of 
the radioactive ligand at 37°C, the steroid-depleted 
cells were able to rebind up to control levels of  ligand 
(Fig. 2). This  response was essentially similar to that 
reported for different subtypes of  the L1210 cell line 
[20]. The  effect on high affinity ligand binding of 
longer '(6 and 16h) dexamethasone incubation was 
also investigated. It was found that cells under  both 
conditions were still able to (re)bind the ligand in a 
high affinity manner  to approx. 70% of the control 
value in cells pre-incubated for the 16h with the 
steroid. 
Cytosolic receptors and receptor-associated hspgO can be 
detected in high levels in $49  cells irrespectively of 
dexamethasone incubation 
The  data in Fig. 2 suggested that the high affinity 
binding conformation of the receptor-- indicat ive 
for hsp90 associationmis present, despite prolonged 
incubation with the ligand. To  investigate the protein 
composition of  GRs during agonist incubation, concen- 
trated cytosols were prepared from cells incubated with 
dexamethasone (10-  7 M) for various times. In order to 
preserve receptor-associated hsp90 during preparation 
of the cytosols, 20 m M  of Na2MoO4 was included in 
the lysis buffer. Control experiments had shown that 
molybdate was capable of preventing the agonist- and 
temperature-mediated loss of hsp90 at 20 as well as 
37°C in cytosols (data not shown). Immunoaftinity 
isolated receptors were detectable in the cytosolic frac- 
tion, irrespective of the length of exposure to dexa- 
methasone [Fig. 3(A)]. Moreover,  hsp90 was found to 
be a component  of the immunoprecipitated complex. 
Quantification with [125I]SAM IgG showed that both 
proteins were present in high levels. Indeed, results 
from three independent experiments showed no de- 
tectable downregulation of the cytoplasmic GR and 
complexed hsp90 during 2, 6 or 16 h of dexamethasone 
incubation [Fig. 3(B)]. 
GR translocation in $49  cells is rapid and reversible but 
not quantitative 
The  outcome of the above experiments is char- 
acteristic of a predominantly non-activated receptor 
population. To  examine the translocation competence 
of GRs, the nuclear and cytosolic compartments 
from control and dexamethasone-challenged cells 
were assayed for receptor content. After cell fraction- 
ation, a 97kDa,  anti-receptor antibody-responsive 
signal was obtained from the cytoplasmic compartment 
in control cells only. Incubations with 1 0 - 7 M  of 
dexamethasone for 2 h resulted in the appearance of 
a nuclear (250mM NaC1 resistant, 5 0 0 m M  NaC1 
extractable) signal (Fig. 4, lane 6). It is obvious, 
however, that most of the receptor protein was 
still present in the cytosolic fraction at all conditions 
(Fig. 4). Limited nuclear translocation could be 
detected after dexamethasone incubations as brief as 
5 min (data not shown), but did not increase during 
more prolonged incubation. Withdrawal of the steroid 
resulted in the disappearance of the nuclear receptor 
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signal  w i th in  2 h (Fig. 4, lane 7). By t25I-relabeling of 
the bands ,  it was es t imated  that  the t rans located  pool  
of receptors  represen ted  approx.  20% of the total  
endogenous  receptor.  I n d e p e n d e n t  repeats,  b u t  p robed  
wi th  the M A I - 5 1 0  an t i body  ( B u G R 2  clone) showed 
s imilar  results.  
Activation of GRs in concentrated cytosols is less effective 
at 37 than at 20°C 
Efficient re label ing,  pers is tant  c o - i m m u n o p r e c i p i t a -  
t ion  of hsp90 and  l imi ted  nuc lear  t rans loca t ion  are all 
indicat ive for non-ac t iva ted  receptors.  There fore ,  the 
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Fig. 3. The effect of 10-7M dexamethasone on GR levels and receptor-associated hsp90 in S49 cells. 
a(A) Autoradiogram of t2SI-labeled Western blots of immunoprecipitated GR, probed for receptor (left panel) 
and receptor-associated hsp90 (right panel). S49 cells were incubated with dexamethasone and after various 
time intervals analyzed for GR and GR associated hsp90. Corresponding conditions are depicted above each 
lane. ni: non- immune serum, c: control, 2, 6 and 16 represent the incubation time in hours in 10-7M 
dexamethasone. (B) GR levels (closed bars) and receptor-associated hsp90 (open bars) in cytosols from 
dexamethasone-incubated $49 cells. Result are the mean + SEM of three independent experiments and 
expressed as a percentage of untreated control. 
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Fig. 4. Limited and revers ib le  trans locat ion  of GRs in S49 
cells. Cells were  cha l l enged  with 1 0 - 7 M  d e x a m e t h a s o n e ,  
lysed  and cytoso l ic  and nuclear  fract ions  were  analyzed 
for GR. Lanes  1--4, cytosol ic  fractious; lanes 5-8, nuclear  
fractions; lanes  1 and 5, no steroid; lanes 2 and 6, 2h of 
dexamethasone ;  lanes  3 and 7 and 4 and 8, as in lanes 2 and 
6 but pos t - incubated  in agonis t - free  growth  medium for 
2 and 4 h, respect ive ly .  
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activational competence of the receptors was examined. 
To  this end, concentrated cytosols were incu- 
bated in the cold with 1 0 - 7 M  of dexamethasone 
and subsequently heated to either 20, 30 or 37°C. 
After 30, 60, 90 and 120 min, aliquots were taken and 
receptor activation was stopped by quickly cooling and 
addition of Na2MoO4. The  samples were incubated 
with the MAI-510  antibody and assayed for receptor 
associated hsp90 by Western blotting. During the 
incubations at 30 and 37°C hsp90 was isolated through- 
out the time course (Fig. 5, middle and lower panel, 
lanes 3, 4 and 5). By contrast a steady decrease 
in receptor associated hsp90 was observed when the 
activation temperature was 20°C (Fig. 5, top panel, 
lanes 3, 4 and 5). Each temperature condition was 
repeated at least twice and similar observations were 
made. 
Fig. 6. Activation of pre-warmed GRs at 20°C. Dexa- 
methasone-loaded cytosols  were  incubated  for 1 h at 37°C. 
Next a s amp le  was put  on ice or further  incubated  for l h at 
20°C. Both s amp le s  were  analyzed by immunoprecipitation 
for receptor-complexed hsp90. Conditions are shown above 
each lane, ni, non-immune serum; c, control  (no dex+ 
MOO4); 37°C, 1 h at 37°C; 20, 1 h at 37°C and 1 h at 20°C. 
The conditions present at 37°C did not irreversibly 
inhibit receptor activation capacity. This was demon- 
strated in Fig. 6, as receptors in dexamethasone 
(10-7 M) loaded cytosol pre-incubated at 37°C for 1 h 
(lane below 37°C), were still activational competent 
when cooled to 20°C (lane below 20°C). By Western 
blotting with the BuGR2 Ab it was found that only 
very limited receptor breakdown occurred during the 
course of the experiment (data not shown), confirming 
20°C 
1 2 3 4 5 
I - - h s p 9 0  
30°C hsp90 
37°C - - h s p 9 0  
Fig. 5. In v i tro  act ivat ion  of  GRs  at different t emp era tu res .  Cytosols  were  incubated  overnight  with 10-7 M 
d e x a m e t h a s o n e  at 4°C. Next  the t e m p e r a t u r e  was  raised to 20, 30 or  37°C. Al iquots  were  taken at var ious  t i m e  
intervals ,  i m m u n o p r e c i p i t a t e d  and a s sayed  for receptor -as soc ia ted  hsp90 by Western  blott ing.  Lane 1, 
n o n - i m m u n e  serum; lane 2, control  (t = 0); lane 3, 30 min; lane 4, 60 rain; lane 5, 120 min.  
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the structural integrity of the receptor in the activation 
experiment. 
D I S C U S S I O N  
Glucocorticoid signaling is mediated by an intra- 
cellular heteromeric receptor protein containing one 
steroid recipient molecule and probably a dimer of 
hsp90. The presence of hsp90 in the GR complex is 
identified with the suppression of DNA binding 
capacity and the maintenance of a high affinity binding 
pocket for its cognate ligand. Administration of gluco- 
corticoids prones lymphoid cells for apoptosis (pro- 
grammed cell death). However, the required steroid 
incubation time varies from <3 h for non-cycling 
thymocytes to 48 h for several dexamethasone-sensitive 
cell lines [23, 24]. 
Among lymphoid cell lines, S49 cells are the most 
sensitive, yet they require 12-16 h of steroid exposure 
for full lysis induction and can be successfully rescued 
from apoptosis by withdrawal of the agonist before the 
critical incubation time has been achieved (Fig. 1). 
We asked if the necessity for prolonged steroid incu- 
bation could be explained by an insufficiently activated 
receptor population. To this end, GRs, in $49 cells 
committed to lysis, were compared with receptors from 
control cells or cells from the pre-commitment phase. 
Receptor characteristics were analyzed in three inde- 
pendent ways: high affinity dexamethasone (re)binding, 
hsp90-receptor association and nuclear translocation. 
Re-labeling studies revealed that high affinity binding 
capacity was present in dexamethasone-incubated cells 
in levels comparable to those in control cells (Fig. 2). 
Likewise, hsp90 could co-immunoprecipitate in high 
levels with the GRs from dexamethasone-challenged 
cells (Fig. 3). Finally, dexamethasone was capable of 
relocating the receptor to the nucleus, but the fraction 
of translocated receptor at any time during dexametha- 
sone incubation was small and the process was fully 
reversible (Fig. 4). Thus, limited and reversible recep- 
tor activation, sufficient to initiate a lytic programme, 
could be confirmed in intact $49 cells at physiolog- 
ical temperature in three independent experimental 
approaches: ligand re-binding, hsp90 co-isolation and 
nuclear translocation. These observations are in plain 
contrast with receptor activation studies in cytosols in 
which agonist binding caused rapid and irreversible 
transformation of the receptor. 
Steroid-induced hsp90 dissociation from the recep- 
tor complex has been linked to the unmasking of a 
nuclear localization sequence and is therefore linked 
to receptor translocation [25]. There are conflicting 
reports on the degree of agonist-mediated translocation 
of the GR in $49 cells at physiological temperature. 
Segnitz and Gehring [19] have reported nearly 
complete depletion of cytoplasmic receptors by tri- 
amcinolone acetonide (TA). Distelhorst and Howard 
[18], using the same cell-type, showed that a significant 
amount (up to 60%) of the GR was still present in 
the cytosolic fraction after dexamethasone (DEX) incu- 
bations. As TA is only a slightly more potent agonist 
than DEX, it is unlikely that the discrepancy between 
these observations can be explained by the different 
steroids used in the experiments. Due to the different 
focus of these studies, further analysis of the receptor 
complex was only addressed to a limited extent. The 
use of concentrated cytosols to avoid receptor acti- 
vation by dilution and the early inclusion of molybdate 
in our experiments has allowed the detection of limited 
activation and nuclear translocation of GRs in GC- 
sensitive $49 cells. Our results indicate that only 
a minor fraction of GRs is activated during steroid 
treatment. This finding, however, does not exclude 
nuclear translocation of the GR while still complexed 
with hsp90, as was demonstrated by hsp90 complexed, 
nuclear located receptors in GR.cDNA transfected 
CHO cells overexpressing the GR [26, 27]. Likewise, 
the detection of receptors complexed to hsp90 can not 
be taken as evidence that activation has not occurred. 
It is possible that nuclear receptors, devoid of 
hsp90, are exported to the cytoplasm where they are 
re-assembled with hsp90. Evidence for this cyclic re- 
ceptor model has been presented previously [28, 29]. 
Furthermore, it appears that in $49 cells only low 
steady state levels of activated receptors are required, 
estimated to amount to approx. 20% ( =  about 3000 
molecules per cell) of total endogenous receptors. 
The finding that only a minor fraction of the total 
receptor population is associated with the nuclear com- 
partment during steroid incubations raises the question 
what mechanisms control the receptor activation and 
nuclear translocation. A role for the heat shock proteins 
present in the GR complex has been suggested [30]. 
Hsp70 and 90 have been shown to be involved in 
intracellular and transmembrane protein trafficking 
[31]. More recently, the involvement of hsp56 has also 
been proposed by Pratt et al. [32]. Post-translational 
modification of the receptor has also been suggested as 
a regulatory element in intra-cellular receptor traffick- 
ing. Dalman et al. and others [33, 34] have reported 
on the steroid-dependent (hyper)phosphorylation of 
the rat GR. A putative phosphatase dependence of the 
activation/translocation process has been documented 
by DeFranco et al. [28] and molybdate, capable of 
counteracting receptor activation, is acknowledged to 
be a phosphatase inhibitor [35]. 
We have reported here on a possible role for the 
thermolability of the ligand-receptor complex at 
37°C as a negative regulator of receptor activation. 
This is primarily based on the thermolabile ligand- 
receptor interaction at 37°C and the consequent re- 
binding capacity. Furthermore, in vitro receptor 
activation is concentrated cytosols showed that acti- 
vation at physiological temperature is less effective 
as compared to lower temperatures, e.g. room tem- 
perature (Fig. 5). 
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T h e  stability of  the l igand-receptor complex  is much  
lower at 37°C than at room temperature [20], it 
is possible that the half-life o f  the l igand-receptor 
association at physiological  temperatures is too short 
for efficient transformation. The  cause for this thermo-  
labile l igand-receptor association can not be deduced 
from our present results. The  effects could be due to 
(enzymic)  modifications of  the heteromeric complex  
or be a direct consequence  of  temperature and the 
structure of  the steroid binding pocket. 
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